Voxp.Wa
VOXP.WA operates in the healthcare sector, primarily engaged in pharmaceuticals, and generates revenue through the provision of healthcare services and equipment.
Business. VOXP.WA operates in the healthcare sector, primarily engaged in pharmaceuticals, and generates revenue through the provision of healthcare services and equipment.
Analyst recommendations
3 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
VOXP.WA operates in the healthcare sector, primarily engaged in pharmaceuticals, and generates revenue through the provision of healthcare services and equipment.
VOXP.WA maintains a debt-to-equity ratio of 0.45, indicating a relatively conservative capital structure, and a current ratio of 1.4, suggesting moderate liquidity. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints.
The company's profitability is reflected in a return on equity of 24.1% and a return on assets of 13.94%, both of which are strong indicators of efficient use of equity and assets. These figures suggest that VOXP.WA is performing well in terms of generating returns for its shareholders and utilizing its assets effectively.
VOXP.WA's financial snapshot does not provide detailed segment or geographic revenue data, making it difficult to assess the company's exposure to specific markets or the concentration of its revenue. However, the company's operations are primarily within the healthcare sector, which is a global industry.
The company's growth trajectory is not explicitly detailed in the provided data, but the operating cash flow of 116,687,400 PLN and free cash flow of 32,055,900 PLN suggest that it has the capacity to fund operations and potentially invest in growth opportunities. The capital expenditure of -75,821,400 PLN indicates that the company is investing in its operations.
The risk assessment for VOXP.WA indicates a medium level of liquidity risk and a low level of dilution risk. The company's net cash position being negative after subtracting total debt is a key flag that could impact its liquidity. The dilution risk is low, which is a positive sign for shareholders.
Recent events related to VOXP.WA are not detailed in the provided data, but the company's financial performance and risk profile suggest that it is a stable player in the healthcare sector. The company's financials and risk assessment indicate that it is in a position to manage its operations and potentially grow.
- VOXP.WA has a strong return on equity and return on assets, indicating efficient use of equity and assets.
- The company's debt-to-equity ratio is relatively low, suggesting a conservative capital structure.
- VOXP.WA's liquidity is moderate, with a current ratio of 1.4, but its net cash position is negative after subtracting total debt.
- The company's growth potential is supported by its operating and free cash flows, although detailed segment and geographic data are not provided.
- The risk assessment indicates a medium level of liquidity risk and a low level of dilution risk.
- margin_outlook_rationale: The company's strong return on equity and return on assets suggest that it is efficiently managing its margins.
- rd_outlook_rationale: The company's capital expenditure indicates investment in operations, which could support future research and development.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 10,94 |
| Revenue | —no estimate | —no estimate | 644,3M PLN |
| Operating income | —no estimate | —no estimate | 151,6M PLN |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- VOXP.WA Market data — financials · 2026-05-29
- Voxel SA Market data — analyst estimates · 2026-05-29